SAPHO syndrome: case report

被引:0
作者
Misiak-Galazka, Magdalena [1 ]
Jeziorkowska, Renata [1 ]
Sikorska-Siudek, Katarzyna [2 ]
Wolska, Hanna [1 ]
机构
[1] Warsaw Med Univ, Dept Dermatol, PL-02008 Warsaw, Poland
[2] Inst Reumatol, Dept Early Arthrit Diag, Warsaw, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2012年 / 29卷 / 02期
关键词
SAPHO; palmoplantar pustulosis; pustular psoriasis; spondyloarthropathies; HYPEROSTOSIS-OSTEITIS SAPHO; PUSTULOSIS; ACNE; SYNOVITIS;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
SAPHO syndrome is characterized by synovitis, acne, pustulosis, hyperostosis and osteitis. Dermatological manifestations include palmoplantar pustulosis, pustular psoriasis in other sites of the body, psoriasis vulgaris, acne (often severe, conglobata or fulminans), hidradenitis suppurativa. The vertebral arthritis associated with the disease belongs to a group of seronegative spondyloarthropathies. The aim was presenting a case of SAPHO syndrome which developed in a patient suffering from palmoplantar pustulosis. We present a patient who developed pustulosis palmoplantaris and low back pain at the same time. The diagnosis of SAPHO syndrome was established on clinical appearance and results of additional tests. The patient was treated with methotrexate in dose initially 15 mg, then 25 mg once a week, non-steroidal anti-inflammatory drugs and topical treatment with improvement. The pain of the chest wall or multifocal arthritis affecting the patient with palmoplantar pustulosis or severe acne should arouse suspicions of SAPHO syndrome.
引用
收藏
页码:136 / 138
页数:3
相关论文
共 12 条
[1]   Adalimumab Treatment for SAPHO Syndrome [J].
Arias-Santiago, Salvador ;
Sanchez-Cano, Daniel ;
Luis Callejas-Rubio, Jose ;
Antonia Fernandez-Pugnaire, Maria ;
Ortego-Centeno, Norberto .
ACTA DERMATO-VENEREOLOGICA, 2010, 90 (03) :301-302
[2]  
CHAMOT AM, 1987, REV RHUM, V54, P187
[3]  
Gmyrek R, 1999, CUTIS, V64, P253
[4]   Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab [J].
Iqbal, M ;
Kolodney, MS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) :S118-S120
[5]   THE SAPHO SYNDROME [J].
KAHN, MF ;
KHAN, MA .
BAILLIERES CLINICAL RHEUMATOLOGY, 1994, 8 (02) :333-362
[6]  
Magrey Marina, 2009, Curr Rheumatol Rep, V11, P329
[7]   In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations [J].
Massara, A. ;
Cavazzini, P. L. ;
Trotta, F. .
RHEUMATOLOGY, 2006, 45 (06) :730-733
[8]   Successful treatment of SAPHO syndrome with infliximab: report of two cases [J].
Olivieri, I ;
Padula, A ;
Ciancio, G ;
Salvarani, C ;
Niccoli, L ;
Cantini, F .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (04) :375-376
[9]   The SAPHO syndrome: a clinical and imaging study [J].
Salles, Meritxell ;
Olive, Alejandro ;
Perez-Andres, Ricard ;
Holgado, Susana ;
Mateo, Lourdes ;
Riera, Elena ;
Tena, Xavier .
CLINICAL RHEUMATOLOGY, 2011, 30 (02) :245-249
[10]   SAPHO Syndrome with Unusual Cutaneous Manifestations Treated Successfully with Etanercept [J].
Vilar-Alejo, Jaime ;
Dehesa, Luis ;
de la Rosa-del Rey, Pilar ;
Novoa-Medina, Javier ;
Valeron Almazan, Pedro ;
Santana Medina, Nestor ;
Bastida, Jesus .
ACTA DERMATO-VENEREOLOGICA, 2010, 90 (05) :531-532